NFKB1 and myeloid neoplasm: Cluster C2 was characterized by a high expression of IFN-γ signaling components and NF-kB as well as a higher immune cell infiltration, which is in line with the described survival benefits of patients with myeloid malignancies exhibiting an activated immune TME [35, 36, 48].